Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-06-16
1996-06-11
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546128, 546130, 546125, 546126, C07D45106, C07D45112, A61K 3146
Patent
active
055256139
ABSTRACT:
The present invention relates to a novel class of covalently coupled benzoylecgonine, ecgonine and ecgonidine derivatives that are useful for alleviating the symptoms of immunoregulatory disorders, neuromuscular disorders, joint disorders, connective tissue disorders, circulatory disorders and pain. Accordingly, this invention also relates to pharmaceutical compositions and methods for their use.
REFERENCES:
patent: 2893996 (1959-07-01), Rudner et al.
patent: 2948730 (1960-08-01), Rudner et al.
patent: 4469700 (1984-09-01), Somers
patent: 4512996 (1985-04-01), Somers
patent: 4556663 (1985-12-01), Somers
W. H. Anderson and D. T. Stafford, "Applications of Capillary Gas Chromatography in Routine Toxicological Analyses", High Resolut. Chromatogr., Chromatogr. Commun., 6(5), pp. 247-254 (1983).
E. J. Ariens and A. M. Simonis, "A Molecular Basis for Drug Action. The Interaction of One or More Drugs with Different Receptors", J. Pharm. Pharmacol., 16, pp. 289-313 (1964).
M. R. Bell and S. Archer, "L(+)-2-Tropinone", J. Amer. Chem. Soc., 82, pp. 4642-4644 (1960).
R. Bingham, "Esterene in the Treatment of Rheumatoid Arthritis", Arthritis News Today, 2(7), pp. 1-4 (1980).
C. S. Boyer and D. R. Peterson, "Enymatic Basis for the Transesterification of Cocaine in the Presence of Ethanol: Evidence for the Participation of Microsomal Carboxylesterases", J. Pharmacol. Exp. Ther., 260(3), pp. 939-946 (1992).
M. R. Brzezinski et al., "Covenient Synthesis of Benzoylecgonine Ethyl Ester, a Homolog of Cocaine", Synth. Commun., 22(7), pp. 1027-1032 (1992).
R. D. Budd, "Cocaine Radioimmunoassay--Structure Versus Reactivity", Clin. Toxicol., 18(7), pp. 773-782 (1981).
D. T. Chia and J. A. Gere, "Rapid Drug Screening Using Toxi-Lab Extraction Followed by Capillary Gas Chromatography/Mass Spectroscopy", Clin. Biochem., 20(5), pp. 303-306 (1987).
A. J. Clark, "the Antagonism of Acetyl Choline by Atropine", J. Physiol., 61, pp. 547-556 (1926).
E. J. Cone et al., "Testing Human Hair for Drug Abuse. II. Identification of Unique Cocaine Metabolites in Hair of Drug Abusers and Evaluation of Decontamination Procedures", J. Anal. Toxicol., 15(5), pp. 250-255 (1991).
R. A. Dean et al., "Human Liver Cocaine Esterases: Ethanol-Mediated Formation of Ethylcocaine", FASEB J., 5(12), pp. 2735-2739 (1991).
F. Fish and W. D. C. Wilson, "Excretion of Cocaine and its Metabolites in Man", J. Pharm. Pharmac., 21 suppl., pp. 135s-138s (1969).
J. R. Fozard et al., "Blockade of Serotonin Receptors on Autonomic Neurones by (-)-Cocaine and Some Related Compounds", Eur. J. Pharmacol., 59(3-4), pp. 195-210 (1979).
J. R. Fozard et al., "Structure-Activity Relationship of Compounds Which Block Receptors for 5-Hydroxytryptamine on the Sympathetic Nerves of the Rabbit Heart", Br. J. Pharmacol., 61(3), pp. 499P-500P (1977).
J. H. Gaddum, "The Action of Adrenalin and Ergotamine on the Uterus of the Rabbit", J. Physiol., 61, pp. 141-150 (1926).
J. H. Gaddum, "The Quantitative Effects of Antagonistic Drugs", J. Physiol., 89, pp. 7-9 (1937).
C. Hansch and W. J. Dunn, "Linear Relationships Between Lipophilic Activity and Biological Activity of Drugs", J. Pharm. Sci., 61, pp. 1-19 (1972).
W. L. Hearn et al., "Cocaethylene: A Unique Cocaine Metabolite Displays High Affinity for the Dopamine Transporter", J. Neurochem., 56(2), pp. 698-701 (1991).
W. L. Hearn et al., "Cocaethylene is More Potent than Cocaine in Mediating Lethality", Pharmacol., Biochem. Behav., 39(2), pp. 531-533 (1991).
G. W. Hime et al., "Analysis of Cocaine and Cocaethylene in Blood and Tissues by GC-NPD and GC-ion Trap Mass Spectrometry", J. Anal. Toxicol., 15(5), pp. 241-245 (1991).
P. Jatlow et al., "Cocaethylene: A Neuropharmacologically Active Metabolite Associated with Concurrent Cocaine-Ethanol Ingestion", Life Sci., 48(18), pp. 1787-1794 (1991).
J. L. Katz et al., "Comparative Behavioral Pharmacology and Toxicology of Cocaine and its Ethanol-Derived Metabolite, Cocaine Ethyl-Ester (Cocaethylene)", Life Sci., 50(18), pp. 1351-1361 (1992).
A. Leo et al., "Partition Coefficients and Their Uses", Chemical Reviews, 71, pp. 525-616 (1971).
A. H. Lewin, "2.beta.-Substituted Analogs of Cocaine. Synthesis and Inhibition of Binding to the Cocaine Receptor", J. Med. Chem., 35(1), pp. 135-140 (1992).
T. Lukaszewski and W. K. Jeffery, "Impurities and Artifacts of Illicit Cocaine", J. Forensic Sci., 25(3), pp. 449-507 (1980).
H. H. McCurdy, "Quantitation of Cocaine and Benzoylecgonine after JETUBE Extraction and Derivitazation", J. Anal. Toxicol., 4(2), pp. 82-85 (1980).
Medical World News, "FP Giving Cocaine for Arthritis is Beset But Gains a Major Ally", pp. 19-20 (1979).
A. L. Misra and S. J. Mule, "Calcium-Binding Property of Cocaine and Some of its Active Metabolites--Formation of Molecular Complexes", Res. Comm. Chem. Pathol. Pharmacol., 11(4), pp. 663-669 (1975).
A. L. Misra et al., "Disposition of [.sup.3 H]-Benzoylecgonine (Cocaine Metabolite) in the Rat", Res. Commun. Chem. Pathol. Pharmacol., 13(4), pp. 579-584 (1976).
A. L. Misra et al., "Estimation and Disposition of [.sup.3 H]-Benzoylecgonine and Pharmacological Activity of Some Cocaine Metabolites", J. Pharm. Pharmac., 27, pp. 784-786 (1975).
A. L. Misra et al., "Physiologic Distribution and Metabolism of [.sup.3 H]-Benzoylecgonine (Cocaine Metabolite) in the Rat", Res. Commun. Chem. Pathol. Pharmacol., 8, pp. 55-63 (1974).
C. Moore et al., "Determination of Cocaine and its Metabolites in Brain Tissue Using High-Flow Solid-Phase Extraction Columns and High-Performance Liquid Chromatography", Forensic Sci. Int., 53(2), pp. 215-219 (1992).
S. Mule et al., "Intracellular Disposition of [.sup.3 H]-Cocaine, [.sup.3 H]-Norcocaine, [.sup.3 H]-Benzoylecgonine and [.sup.3 H]-Benxoylnorecgonine in the Brain of Rats", Life Sci., 19, pp. 1585-1596 (1976).
M. Perez-Reyes and A. R. Jeffcoat, "Ethanol/Cocaine Interaction:Cocaine and Cocaethylene Plasma Concentrations and Their Relationship to Subjective and Cardiovascular Effects", Life Sci., 51(8), pp. 553-563 (1992).
M. Polasek et al., "Determination of Limiting Ionic Mobilities and Dissociation Constants of Some Local Anaesthetics", J. Chomatogr., 596, pp. 265-270 (1992).
F. K. Rafla and R. L. Epstein, "Identification of Cocaine and its Metabolites in Human Urine in the Presence of Ethyl Alcohol", J. Anal. Toxicol., 3(2), pp. 59-63 (1979) R33(5/5), R39(20/20).
M. E. A. Reith et al., "Locomotor Effects of Cocaine, Cocaine Congeners and Local Anesthetics in Mice", Pharmacol., Biochem. Behav., 23(5), pp. 831-836 (1985).
M. E. A. Reith et al., "Structural Requirements for Cocaine Congeners to Interact with [.sup.3 H] Bactachotoxinin a 20-.alpha.-Benzoate Binding Sites on Sodium Channels in Mouse Brain Synaptosomes", J. Biol. Chem., 261(16), pp. 7300-7305 (1986).
M. E. A. Reith et al., "Structural Requirements for Cocaine Congeners to Interact with Dopamine and Serotonin Uptake Sites in Mouse Brain and to Induce Sterotyped Behavior", Biochem. Parmacol., 35(7), pp. 1123-1129 (1986).
S. M. Roberts et al., "An assay for Cocaethylene and Other Cocaine Metabolites in Liver Using High-Performance Liquid Chromatography", Anal. Biochem., 202(2), pp. 256-261 (1992).
S. M. Roberts et al., "Cocaethylene Hepatoxicity in Mice", Biochem. Pharmacol., 43(9), pp. 1989-1995 (1992).
R. H. Rohrbaugh and P. C. Jurs, "Prediction of Gas Chromatographic Retention Indexes for Diverse Drug Compounds", Anal. Chem., 60(20), pp. 2249-2253 (1988).
Schmidt and Werner, "Synthetischer Einbau von .sup.14 C in (-)-Cocain, (-)-Ekgonin und Derivate", Ann. pp. 184-194 (1962) ("Schmidt").
R. M. Smith, "Ethyl Esters of Arylhydroxy- and Arylhydroxymethoxycocaines in the Urines of Simultaneous Cocaine and Ethanol Users", J. Anal. Toxicol., 8(1), pp. 38-42 (1984).
R. P. Stephenson, "A Modification of Receptor Theory", Br. J. Pharmacol., 11, pp. 379-393 (1956).
D. L. Von Minden and N. A. D'Amato, "Simultaneous Determination of Cocaine and Benzoylecgonine in Urine by Gas-liquid Chromatography", Anal. Chem., 49(13), pp. 1974-1977 (1977).
G. Werner and K. H. Stoerr, "Labeled Tropane Alkaloids. VI. Synthesis of Psicaine-nue N-
Somers Lowell M.
Wynn James E.
Entropin, Inc.
Hsi Jeffrey D.
Loring Denise L.
Rotman Alan L.
LandOfFree
Covalently coupled benzoylecgonine ecgonine and ecgonidine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Covalently coupled benzoylecgonine ecgonine and ecgonidine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Covalently coupled benzoylecgonine ecgonine and ecgonidine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-351831